eNauka - pregled

Pregled prema Autor Genovese, Mark C

Prikaz rezultata 1 do 3 od 3
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2019Efficacy and Safety of Fenebrutinib, a BTK Inhibitor, Compared to Placebo in Rheumatoid Arthritis Patients with Active Disease Despite TNF Inhibitor Treatment: Randomized, Double Blind, Phase 2 StudyCohen, Stanley B; Tuckwell, Katie; Kunder, Rebecca; Katsumoto, Tamiko R; Zhao, Rui; Berman, Alberto; Damjanov, Nemanja S; Fedkov, Dmytro; Jeka, Slawomir; Genovese, Mark CKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2019Fenebrutinib Compared to Placebo and Adalimumab in Patients with Inadequate Response to Either Methotrexate Therapy Or Prior Tnf Therapy: Phase 2 StudyCohen, Stanley B; Tuckwell, Katie; Katsumoto, Tamiko R; Zhao, Rui; Lee, Chin; Berman, Alberto; Damjanov, Nemanja S; Fedkov, Dmytro; Jeka, Slawomir; Genovese, Mark CKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2013Oskira-2: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To Disease-Modifying Antirheumatic Drugs.Dawes, Peter; Dimic, Aleksandar N; Genovese, Mark C; van, der Heijde Desiree; Jenkins, Martin; O'Brien, Chris; Oemar, Barry; Vencovsky, Jiri; Weinblatt, MichaelKonferencijski rad
Mp kategorija će biti prikazana naknadno.